Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance - Hardcover

Über die Autorinnen und Autoren

Dr Bonavida has vast expertise and various reported publications in the field of tumor cell sensitization to chemotherapy (a total of greater than 500 publications) and in particular the novel role of Nitric Oxide (NO) donors in chemo-sensitization and reversal of drug resistance. In addition, he was the first scientist to co-organize an international meeting on the topic (First International Workshop on NO and Cancer, 2005).

Dr. Anahid Jewett, PhD, MPH, is well-known nationally and internationally for her contribution to the field of NK biology, tumor immunology and cancer immunotherapy. She serves on the editorial board of many prestigious journals and has been a reviewer on the board of National Institute of Health study sections. She holds several patents and has published more than 100 high impact journal articles, reviews, commentaries and book chapters in the field of cancer. Dr. Jewett’s major contributions to science and NK cell biology were the identification, characterization and the establishment of the concept of split anergy in NK cells, establishment of the role of NK cells in elimination, selection and differentiation of cancer stem cells as well as healthy stem cells, and methods to generate large numbers of super-charged NK cells which are in use currently in clinical trials of cancer patients.

Von der hinteren Coverseite

Successes and Challenges of NK Immunotherapy: Increasing Anti-tumor Efficacy describes the very novel and unique therapeutic applications of NK cells to fight cancers and, primarily, eliminate both the bulk and the subset of cancer stem cells responsible for metastasis, relapse and recurrences. It provides up to date information on the development, engineering, mechanisms of action, response to various preclinical models, and current applications in various clinical trials.

The book covers the state of the art on the development of highly engineered cytotoxic NK cells, their mechanisms of action, preclinical and clinical applications, the development and application of CAR-NK cells, as well as new NK-drug conjugates in order to potentiate their anti-tumor activities. In addition, the book emphasizes that, unlike other immunotherapeutic approaches, the activated NK cells can also target and kill the highly resistant cancer stem cells that are responsible for the relapses and recurrences by all other therapeutic treatments.

Written by the leading experts on NK immunotherapy worldwide, this is a valuable resource for researchers, clinicians, and members of biomedical field who are interested in understanding novel and efficient therapies to fight cancers.